Ask AI
S. 2609

Facilitating Innovative Nuclear Diagnostics Act of 2021

Facilitating Innovative Nuclear Diagnostics Act of 2021

This bill establishes separate payment requirements for diagnostic radiopharmaceuticals under the Medicare prospective payment system for hospital outpatient department services. The bill's requirements apply to diagnostic radiopharmaceuticals that have an average daily cost of $500 or more in 2022 and as adjusted based on a specified fee schedule factor in each year thereafter.

Read twice and referred to the Committee on Finance.

Sen. Blackburn, Marsha [R-TN](R-TN)Sponsor
5 cosponsors3 D2 R
5cosponsors1committees2actions1related bills4subjects
  1. IntroReferral

    Read twice and referred to the Committee on Finance.

    Finance Committee
  2. IntroReferral10000

    Introduced in Senate

Facilitating Innovative Nuclear Diagnostics Act of 2021 — Informed